Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)

v3.20.1
Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Subscriptions Receivable [Member]
Subscriptions Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2018 $ 34,292 $ 1,278,352 $ (602) $ (4,090) $ (1,959,982) $ (101) $ (652,131)
Balance, shares at Dec. 31, 2018 34,291,905              
Cash received on subscriptions receivable of OWP Ventures, Inc. 602 602
Common stock of OWP Ventures, Inc. sold for cash $ 3,900 1,946,100 1,950,000
Common stock of OWP Ventures, Inc. sold for cash, shares 3,900,000              
Issuance of common stock of OWP Ventures, Inc. on debt conversion $ 1,253 500,144 501,397
Issuance of common stock of OWP Ventures, Inc. on debt conversion, shares 1,253,493              
Common stock issued for services, OWP Ventures, Inc. $ 30 14,970 15,000
Common stock issued for services, OWP Ventures, Inc., shares 30,000              
Amortization of common stock options issued for services, OWP Ventures, Inc. 88,297 88,297
Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1) $ 1,323 (10,730) 101 (9,306)
Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1), shares 1,322,501              
Common stock cancelled pursuant to merger with OWP Ventures, Inc. $ (875) 875
Common stock cancelled pursuant to merger with OWP Ventures, Inc., shares (875,000)              
Amortization of common stock options issued for services 165,243 165,243
Beneficial conversion feature on convertible note 125,000 125,000
Loss on foreign currency translation (8,287) (8,287)
Net loss (1,323,516) (1,323,516)
Balance at Mar. 31, 2019 $ 39,923 4,108,251 (12,377) (3,283,498) 852,299
Balance, shares at Mar. 31, 2019 39,922,899              
Balance at Dec. 31, 2019 $ 44,804 8,150,004 250,000 (16,248) (8,167,166) 261,394
Balance, shares at Dec. 31, 2019 44,804,305              
Amortization of common stock options issued for services 141,278 141,278
Common stock sold for cash $ 500 249,500 (250,000)
Common stock sold for cash, shares 500,000              
Common stock issued for services $ 406 421,594 422,000
Common stock issued for services, shares 406,000              
Loss on foreign currency translation (21,359) (21,359)
Net loss (1,187,916) (1,187,916)
Balance at Mar. 31, 2020 $ 45,710 $ 8,962,376 $ (37,607) $ (9,355,082) $ (384,603)
Balance, shares at Mar. 31, 2020 45,710,305